Two Sigma Investments’s Chinook Therapeutics, Inc. Common Stock KDNY Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2023
Q3 | – | Sell |
-88,706
| Closed | -$3.41M | – | 3294 |
|
2023
Q2 | $3.41M | Sell |
88,706
-65,559
| -42% | -$2.52M | 0.01% | 1047 |
|
2023
Q1 | $3.57M | Buy |
154,265
+15,637
| +11% | +$362K | 0.01% | 1010 |
|
2022
Q4 | $3.63M | Sell |
138,628
-82,317
| -37% | -$2.16M | 0.01% | 975 |
|
2022
Q3 | $4.34M | Buy |
220,945
+2,662
| +1% | +$52.3K | 0.01% | 783 |
|
2022
Q2 | $3.82M | Buy |
218,283
+197,801
| +966% | +$3.46M | 0.01% | 853 |
|
2022
Q1 | $335K | Sell |
20,482
-191,110
| -90% | -$3.13M | ﹤0.01% | 2138 |
|
2021
Q4 | $3.45M | Sell |
211,592
-112,853
| -35% | -$1.84M | 0.01% | 1074 |
|
2021
Q3 | $4.14M | Buy |
324,445
+233,448
| +257% | +$2.98M | 0.01% | 998 |
|
2021
Q2 | $1.29M | Buy |
90,997
+73,815
| +430% | +$1.04M | ﹤0.01% | 1569 |
|
2021
Q1 | $267K | Sell |
17,182
-49,948
| -74% | -$776K | ﹤0.01% | 2082 |
|
2020
Q4 | $1.07M | Buy |
67,130
+29,002
| +76% | +$460K | ﹤0.01% | 1312 |
|
2020
Q3 | $463K | Sell |
38,128
-18,155
| -32% | -$220K | ﹤0.01% | 1451 |
|
2020
Q2 | $650K | Buy |
56,283
+40,386
| +254% | +$466K | ﹤0.01% | 1327 |
|
2020
Q1 | $218K | Sell |
15,897
-91,424
| -85% | -$1.25M | ﹤0.01% | 1574 |
|
2019
Q4 | $633K | Buy |
107,321
+47,138
| +78% | +$278K | ﹤0.01% | 1605 |
|
2019
Q3 | $319K | Sell |
60,183
-939
| -2% | -$4.98K | ﹤0.01% | 1624 |
|
2019
Q2 | $471K | Sell |
61,122
-17,267
| -22% | -$133K | ﹤0.01% | 1609 |
|
2019
Q1 | $1.56M | Sell |
78,389
-10,797
| -12% | -$215K | 0.01% | 1259 |
|
2018
Q4 | $1.18M | Buy |
89,186
+82,466
| +1,227% | +$1.09M | ﹤0.01% | 1249 |
|
2018
Q3 | $247K | Buy |
+6,720
| New | +$247K | ﹤0.01% | 1804 |
|
2018
Q1 | – | Sell |
-15,798
| Closed | -$592K | – | 2441 |
|
2017
Q4 | $592K | Buy |
+15,798
| New | +$592K | ﹤0.01% | 1691 |
|
2016
Q1 | – | Sell |
-4,142
| Closed | -$583K | – | 2430 |
|
2015
Q4 | $583K | Buy |
+4,142
| New | +$583K | ﹤0.01% | 1481 |
|